Dr.Chapa'sObGynPearls: Texas A&M College of Medicine
Summary: Evidence based lessons and factual clinical pearls to accompany the Texas A&M College of Medicine ObGyn Clerkship. Dr. Hector Chapa is a Board-Certified ObGyn who has published over 40 clinical studies. Additionally, Dr. Chapa has served as an FDA clinical trial investigator for a variety of gynecological medical devices. He currently serves as Clinical Assistant Professor in the Department of Obstetrics and Gynecology for the Texas A&M College of Medicine. This podcast will keep the OB/GYN medical student, resident, and healthcare provider current across different topics.
- Visit Website
- RSS
- Artist: obgynpearls
- Copyright: obgynpearls 2017
Podcasts:
Review of seizure classifications, diagnosis and work up. The affects of pregnancy on seizure activity and vice versa will be reviewed. Additionally, we will review anti-epileptic medication (AED) use during pregnancy and end with a review on breastfeeding and contraception.
First trimester nuchal translucency with serum markers , 2nd trimester serum testing, combined 1st and 2nd trimester screening protocols, ultrasound, and cell-free DNA (NIPTs) are all options for fetal aneuploidy screening. Here, we will summarize the latest ACOG practice bulletin on the subject (ACOG PB 163, May2016).
Hepatitis B viral load and hepatitis Be antigen status are the most important factors influencing vertical transmission (mother to child infection). In this podcast, we will review hepatitis B infection in pregnancy. Data taken from the American College of Obstetricians and Gynecologists practice bulletin, "viral hepatitis in pregnancy".
A review of the pros and cons of immediate versus delayed umbilical cord clamping. Data extrapolated from ACOG committee opinion number 543.
The Rhesus Antigens (CDE group) is a leading cause of fetal Rh incompatibility potentially resulting in fetal hemolytic anemia or erythroblastosis fetalis. This podcast will review the pathophysiology, work-up, treatment, and prevention of maternal – fetal Rh incompatibility. (SMFM and ACOG Data review).
An estimated 11% of US women report at least one UTI/ year. This podcast will cover the workup and treatment of UTIs in nonpregnant women. Complicated UTI (e.g., in patients with diabetes mellitus, abnormal anatomy, prior urological surgery, history of renal stones, patients with indwelling catheters, or UTIs in spinal cord injuries) will be reviewed separately. Data from ACOG PB #91, and the Infectious Disease Society of America.
VIN is divided into usual type and differentiated type. This podcast will review the current management of this premalignant condition based on ACOG Committee Opinion #509.
A review of the three categories of non-neoplastic epithelial vulvar disorders: lichen sclerosis, lichen planus, and lichen simplex chronicus. HPV related disorders and VIN will be covered in a separate podcast. (Data from ACOG bulletin 93).
Summary of ACOG's practice bulletin (#119) reviewing hypo active sexual desire, organic dysfunction, and sexual pain syndromes. The recently approved medication, Addyi, is also briefly discussed.
Incidence, risk factors, staging and prognosis overview of breast cancer based on ACS/ASCO data.
EIN is a true pre-cancer precursor to endometrial adenocarcinoma (type I). In this podcast, we will review the pathogenesis, work up, and management of EIN based on ACOG/SGO committee opinion #631 (May2015).
GTN encompasses: complete and partial hydatidiform mole, invasive mole, choriocarcinoma and Placental Site Tumor. In this podcast, we will review the incidents, clinical presentation, diagnosis and management of benign molar pregnancies as well as their malignant sequelae. Data extrapolated from ACOG PB #53.
A true obstetrical emergency, Shoulder Dystocia can result in serious maternal-fetal morbidity or even fetal death. We will review the incidence, risk factors, and maneuvers to successfully navigate through this stressful obstetrical event.
A supplement to our prior podcast on PROM, we will review the interim updated clinical management of Preterm PROM based on the ACOG Bulletin (#160) from January 2016.
A clinic review of the presentation, diagnoses, and treatment of the most common causes of low platelets during pregnancy. Data taken from the ACOG and the Society of Maternal-Fetal Medicine.
